Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Liver Diseases Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01337479
What this trial is testing

A Phase IIIb: Long-Term Outcomes for Hepatitis B (HepB) Patients in Some Previous Entecavir (ETV) Trials

Who this might be right for
Hepatitis B
Bristol-Myers Squibb 1,097
Not applicableStudy completedNCT03329820
What this trial is testing

Quality of Life and Health Utility of Patients With CHB Infections

Who this might be right for
Chronic Hepatitis B Infection
The University of Hong Kong 589
Testing effectiveness (Phase 2)Study completedNCT04465890
What this trial is testing

A Phase II Study of Subcutaneously Injected PD-L1 Antibody ASC22 in Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis b
Ascletis Pharmaceuticals Co., Ltd. 207
Not applicableStudy completedNCT00305591
What this trial is testing

Brain Imaging in Patients With Chronic Liver Disease and Functional Impairment.

Who this might be right for
CirrhosisHepatic Encephalopathy
Imperial College London 50
Not applicableStudy completedNCT05317260
What this trial is testing

Steatohepatitis in Chronic Hepatitis B

Who this might be right for
Fatty LiverChronic Hepatitis b
Mahidol University 408
Large-scale testing (Phase 3)Study completedNCT01732796
What this trial is testing

IFN-free Combination Therapy in HCV-infected Patients Treatment-naive:HCVerso1

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 470
Early research (Phase 1)Study completedNCT03038113
What this trial is testing

Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of RO7062931in Healthy Volunteers and Subjects With Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Hoffmann-La Roche 119
Not applicableStudy completedNCT02537379
What this trial is testing

Use-Results Surveillance Study of Sovaldi® Plus Copegus® in Japanese Patients With Chronic Genotype 2 Hepatitis C Virus Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 552
Not applicableUnknownNCT04474262
What this trial is testing

Efficacy of Albumin Plus Midodrine v/s Albumin Alone in Reducing Incidence of Paracentesis Induced Circulatory Dysfunctions in ACLF Patients.

Who this might be right for
Acute-On-Chronic Liver Failure
Institute of Liver and Biliary Sciences, India 150
Not applicableUnknownNCT02412592
What this trial is testing

Sustained Viral Response in Chronic Hepatitis B Patients Who Achieved HBeAg Seroncongversion After Interferon Therapy

Who this might be right for
Chronic Hepatitis B
Beijing Ditan Hospital 260
Early research (Phase 1)Study completedNCT00426712
What this trial is testing

Safety of HEPLISAV™ Hepatitis B Virus Vaccine in End-stage Kidney Failure Patients

Who this might be right for
Hepatitis B
Dynavax Technologies Corporation 42
Testing effectiveness (Phase 2)Looking for participantsNCT05895136
What this trial is testing

A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome (COMBAT Trial).

Who this might be right for
Liver CirrhosisDecompensated Cirrhosis of LiverAcute on Chronic Liver Failure (ACLF)
European Foundation for Study of Chronic Liver Failure 90
Post-approval studies (Phase 4)Ended earlyNCT00255034
What this trial is testing

Effects of 48 Weeks Versus 24 Weeks of Therapy With Peg-Intron/Ribavirin in Patients With Chronic Hepatitis C, Genotype 3 (Study P04143)(TERMINATED)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 146
Not applicableStudy completedNCT02307409
What this trial is testing

Assessment of Coagulation Profile and Haematopoietic Responses in Patients With Acute-on-chronic Liver Failure During Systemic Inflammatory Response (SIRS) and Sepsis

Who this might be right for
Acute on Chronic Liver Failure
Institute of Liver and Biliary Sciences, India 114
Testing effectiveness (Phase 2)Study completedNCT01706575
What this trial is testing

Pegasys (Peginterferon Alfa-2a) Added to Nucleos(t)Ide Analogue Treatment in Participants With HBeAg-Negative Chronic Hepatitis B Genotype D Showing Stable Hepatitis B Virus (HBV) Deoxyribonucleic Acid (DNA) Suppression

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 76
Not applicableStudy completedNCT02201407
What this trial is testing

An Observational Study in Participants With Chronic Hepatitis B (CHB) Receiving Therapy With Peginterferon Alfa-2a 40 Kilodaltons (kD) (PEGASYS) - The PRO B Study

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 50
Post-approval studies (Phase 4)Study completedNCT00830609
What this trial is testing

High Dose Versus Standard Dose of Ribavirin in Patients With Chronic Hepatitis C, Genotype 3

Who this might be right for
Chronic Hepatitis C
Dr. Conrado Fernandez 101
Large-scale testing (Phase 3)Ended earlyNCT02319200
What this trial is testing

Primary Prevention Hepatocellular Carcinoma by Metformin

Who this might be right for
Hepatocellular CarcinomaHepatitis C, ChronicCirrhosis
Assistance Publique - Hôpitaux de Paris 11
Testing effectiveness (Phase 2)Study completedNCT00787371
What this trial is testing

Effect of Low-dose PegIntron on ALT Normalization in Japanese Patients With Chronic Hepatitis C (Study P04508)(COMPLETED)

Who this might be right for
Hepatitis C, ChronicHepatitis C
Merck Sharp & Dohme LLC 69
Not applicableUnknownNCT03754400
What this trial is testing

Efficacy of Albumin Therapy With Standard Medical Treatment (SMT) as Compared to Standard Medical Treatment (SMT) in Improving Patient Survival and Immune Modulation in Patients With Acute on Chronic Liver Failure (ASIA Trial).

Who this might be right for
Acute on Chronic Liver Failure
Institute of Liver and Biliary Sciences, India 200
Next Page